Siemens Dimension Vista 1000T (15959)
Specialty: Toxicology / TDM
Welcome to the PulseAid listing for the Siemens Dimension Vista 1000T medical device. This device is used in the Toxicology / TDM healthcare specialty. Below, you can view the analytes this device is used to test, and its corresponding complexity (HIGH, MODERATE, or CLIA WAIVED). We have also randomly listed additional medical devices used in the Toxicology / TDM healthcare specialty at the bottom of the page.
Analytes Measured/Detected and Complexity:
| ANALYTE | COMPLEXITY |
| Acetaminophen (K051087 | K061655) | MODERATE Effective Date: 2009-09-14 |
| Alanine aminotransferase (ALT) (SGPT) (K051087 | K061020) | MODERATE Effective Date: 2009-09-14 |
| Albumin (K051087 | K061020) | MODERATE Effective Date: 2009-09-14 |
| Alkaline phosphatase (ALP) (K051087 | K061792) | MODERATE Effective Date: 2009-09-14 |
| Alpha-1 microglobulin (X090027 | X090027) | MODERATE Effective Date: 2009-03-25 |
| Alpha-1-acid glycoprotein (orosomucoid) (X090026 | X090026) | MODERATE Effective Date: 2009-05-11 |
| Alpha-1-antitrypsin (K051087 | K063610) | MODERATE Effective Date: 2009-09-14 |
| Alpha-2-macroglobulin (K051087 | K081249) | MODERATE Effective Date: 2009-09-14 |
| Alpha-fetoprotein, maternal serum (K051087 | K071597) | MODERATE Effective Date: 2009-09-14 |
| Amikacin (K051087 | K822657) | MODERATE Effective Date: 2010-05-13 |
| Ammonia, plasma/serum (K051087 | K062316) | MODERATE Effective Date: 2009-09-14 |
| Amylase (K051087 | K061655) | MODERATE Effective Date: 2009-09-14 |
| Apolipoprotein A1 (K051087 | K063608) | MODERATE Effective Date: 2009-09-14 |
| Apolipoprotein B (K051087 | K063608) | MODERATE Effective Date: 2009-09-14 |
| Aspartate aminotransferase (AST) (SGOT) (K051087 | K061020) | MODERATE Effective Date: 2009-09-14 |
| B-type natriuretic peptide (BNP) (K061795 | K061795) | MODERATE Effective Date: 2010-04-30 |
| Barbiturates (K051087 | K062128) | MODERATE Effective Date: 2009-09-14 |
| Benzodiazepines (K051087 | K062128) | MODERATE Effective Date: 2009-09-14 |
| Beta-2 microglobulin (K051087 | K063272) | MODERATE Effective Date: 2009-09-14 |
| Bilirubin, direct (K051087 | K061839) | MODERATE Effective Date: 2009-09-14 |
| Bilirubin, total (K051087 | K061719) | MODERATE Effective Date: 2009-09-14 |
| C-reactive protein (CRP) (K051087 | K061825) | MODERATE Effective Date: 2009-09-14 |
| CA 19-9 (K100375 | K100375) | MODERATE Effective Date: 2011-08-17 |
| Caffeine (K051087 | K042407) | MODERATE Effective Date: 2009-11-17 |
| Calcium, total (K051087 | K061792) | MODERATE Effective Date: 2009-09-14 |
| Cancer antigen 125 (CA 125) (K100321 | K100321) | MODERATE Effective Date: 2011-08-17 |
| Cancer antigen 15-3 (CA 15-3) (K100344 | K100344) | MODERATE Effective Date: 2011-08-17 |
| Cannabinoids (THC) (K051087 | K062128) | MODERATE Effective Date: 2009-09-14 |
| Carbamazepine (K051087 | K061020) | MODERATE Effective Date: 2009-09-14 |
| Carbon dioxide, total (CO2) (K051087 | K061238) | MODERATE Effective Date: 2009-09-14 |
| Carcinoembryonic antigen (CEA) (K051087 | K071603) | MODERATE Effective Date: 2009-09-14 |
| Cerebrospinal fluid (CSF) protein (X090031 | X090031) | MODERATE Effective Date: 2009-04-14 |
| Ceruloplasmin (K051087 | K063655) | MODERATE Effective Date: 2009-09-14 |
| Chloride (K051087 | K051087) | MODERATE Effective Date: 2009-09-14 |
| Cholesterol (K051087 | K061655) | MODERATE Effective Date: 2009-09-14 |
| Cocaine metabolites (K051087 | K062128) | MODERATE Effective Date: 2009-09-14 |
| Complement C1 inhibitor (K051087 | K072965) | MODERATE Effective Date: 2009-09-14 |
| Complement C3 (K051087 | K061852) | MODERATE Effective Date: 2009-09-14 |
| Complement C4 (K051087 | K061852) | MODERATE Effective Date: 2009-09-14 |
| Creatine kinase (CK) (K051087 | K061655) | MODERATE Effective Date: 2009-09-14 |
| Creatine kinase MB fraction (CKMB) (K051087 | K062128) | MODERATE Effective Date: 2009-09-14 |
| Creatinine (K051087 | K061238) | MODERATE Effective Date: 2009-09-14 |
| Cyclosporine (K051087 | K062236) | MODERATE Effective Date: 2009-09-14 |
| Cystatin C (K051087 | K063351) | MODERATE Effective Date: 2009-09-14 |
| Digitoxin (K051087 | K062024) | MODERATE Effective Date: 2009-09-14 |
| Digoxin (K051087 | K062024) | MODERATE Effective Date: 2009-09-14 |
| Estradiol (X110082 | X110082) | MODERATE Effective Date: 2011-08-31 |
| Ethanol (alcohol) (K051087 | K061792) | MODERATE Effective Date: 2009-09-14 |
| Ethosuximide (K832797 | K832797) | MODERATE Effective Date: 2012-08-27 |
| Ferritin (K051087 | K070552) | MODERATE Effective Date: 2009-09-14 |
| Folate (folic acid) (K051087 | K071224) | MODERATE Effective Date: 2009-09-14 |
| Follicle stimulating hormone (FSH) (X110056 | X110056) | MODERATE Effective Date: 2011-06-17 |
| Gamma glutamyl transferase (GGT) (K051087 | K061655) | MODERATE Effective Date: 2009-09-14 |
| Gentamicin (K051087 | K062024) | MODERATE Effective Date: 2009-09-14 |
| Glucose (K051087 | K061655) | MODERATE Effective Date: 2009-09-14 |
| Glycosylated Hemoglobin (Hgb A1c) (K051087 | K062128) | MODERATE Effective Date: 2009-09-14 |
| Haptoglobin (X090028 | X090028) | MODERATE Effective Date: 2009-03-25 |
| hCG, beta, serum, quantitative (K051087 | K063754) | MODERATE Effective Date: 2009-09-14 |
| HDL cholesterol (K051087 | K061655) | MODERATE Effective Date: 2009-09-14 |
| Hemopexin (X090034 | X090034) | MODERATE Effective Date: 2009-03-20 |
| Homocysteine (K051087 | K063206) | MODERATE Effective Date: 2009-09-14 |
| Immunoglobulins IgA (K051087 | K061338) | MODERATE Effective Date: 2009-09-14 |
| Immunoglobulins IgE (K051087 | K063425) | MODERATE Effective Date: 2009-09-14 |
| Immunoglobulins IgG (K051087 | K081161) | MODERATE Effective Date: 2009-09-14 |
| Immunoglobulins IgM (K051087 | K061845) | MODERATE Effective Date: 2009-09-14 |
| Iron (K051087 | K061793) | MODERATE Effective Date: 2009-09-14 |
| Iron binding capacity, total (K051087 | K061020) | MODERATE Effective Date: 2009-09-14 |
| Lactate dehydrogenase (LDH) (K051087 | K061238) | MODERATE Effective Date: 2009-09-14 |
| Lactic acid (lactate) (K051087 | K061792) | MODERATE Effective Date: 2009-09-14 |
| LDL cholesterol (K051087 | K061655) | MODERATE Effective Date: 2009-09-14 |
| Lidocaine (K051087 | K061655) | MODERATE Effective Date: 2009-09-14 |
| Lipase (X090029 | X090029) | MODERATE Effective Date: 2009-04-14 |
| Lithium (K051087 | K061792) | MODERATE Effective Date: 2009-09-14 |
| Luteinizing hormone (LH) (X110058 | X110058) | MODERATE Effective Date: 2011-06-30 |
| Magnesium (K051087 | K061655) | MODERATE Effective Date: 2009-09-14 |
| Methadone (K051087 | K062128) | MODERATE Effective Date: 2009-09-14 |
| Methamphetamine/amphetamine (K051087 | K062128) | MODERATE Effective Date: 2009-09-14 |
| Methamphetamines (K051087 | K062128) | MODERATE Effective Date: 2009-09-14 |
| Methotrexate (K811459 | K811459) | MODERATE Effective Date: 2011-09-20 |
| Methylenedioxymethamphetamine (MDMA) (K062128 | K062128) | MODERATE Effective Date: 2010-04-14 |
| Microalbumin (K051087 | K061990) | MODERATE Effective Date: 2009-09-14 |
| Myoglobin (K051087 | K053576) | MODERATE Effective Date: 2009-09-14 |
| N-acetylprocainamide (NAPA) (K051087 | K062024) | MODERATE Effective Date: 2009-09-14 |
| N-Terminal pro brain natriuretic peptide (ProBNP) (K051087 | K080578) | MODERATE Effective Date: 2009-09-14 |
| Opiates (K102779 | K102779) | MODERATE Effective Date: 2013-03-15 |
| Phencyclidine (PCP) (K051087 | K062128) | MODERATE Effective Date: 2009-09-14 |
| Phenobarbital (K051087 | K051087) | MODERATE Effective Date: 2009-09-14 |
| Phenytoin (K051087 | K062024) | MODERATE Effective Date: 2009-09-14 |
| Phosphorus (K051087 | K061655) | MODERATE Effective Date: 2009-09-14 |
| Potassium (K051087 | K051087) | MODERATE Effective Date: 2009-09-14 |
| Prealbumin (X090024 | X090024) | MODERATE Effective Date: 2009-04-13 |
| Procainamide (K051087 | K061655) | MODERATE Effective Date: 2009-09-14 |
| Prolactin (X110057 | X110057) | MODERATE Effective Date: 2011-06-30 |
| Protein, total (X090032 | X090032) | MODERATE Effective Date: 2009-04-14 |
| Protein, total, urine (X090031 | X090031) | MODERATE Effective Date: 2009-04-14 |
| Pseudocholinesterase (K051087 | K061655) | MODERATE Effective Date: 2009-09-14 |
| Retinol binding protein (RBP) (X090035 | X090035) | MODERATE Effective Date: 2009-03-20 |
| Rheumatoid factor (RF) (K051087 | K062035) | MODERATE Effective Date: 2009-09-14 |
| Salicylates (K051087 | K061655) | MODERATE Effective Date: 2009-09-14 |
| Sodium (K051087 | K051087) | MODERATE Effective Date: 2009-09-14 |
| Theophylline (K051087 | K062024) | MODERATE Effective Date: 2009-09-14 |
| Thyroid stimulating hormone (TSH) (K051087 | K060090) | MODERATE Effective Date: 2009-09-14 |
| Thyroxine (T4) (K051087 | K061655) | MODERATE Effective Date: 2009-09-14 |
| Thyroxine uptake (T4U) (TU) (X090036 | X090036) | MODERATE Effective Date: 2009-04-14 |
| Thyroxine, free (FT4) (K051087 | K053531) | MODERATE Effective Date: 2009-09-14 |
| Tobramycin (K051087 | K061655) | MODERATE Effective Date: 2009-09-14 |
| Transferrin (K051087 | K063322) | MODERATE Effective Date: 2009-09-14 |
| Transferrin receptor (TFR) (K051087 | K063663) | MODERATE Effective Date: 2009-09-14 |
| Transferrin, carbohydrate-deficient (X110081 | X110081) | MODERATE Effective Date: 2011-06-29 |
| Tricyclic antidepressants (K821743 | K821743) | MODERATE Effective Date: 2011-04-15 |
| Triglyceride (K051087 | K061655) | MODERATE Effective Date: 2009-09-14 |
| Triiodothyronine (T3) (X090033 | X090033) | MODERATE Effective Date: 2009-04-14 |
| Triiodothyronine, free (FT3) (X090025 | X090025) | MODERATE Effective Date: 2009-04-14 |
| Troponin-I (cardiac) (K051087 | K063756) | MODERATE Effective Date: 2009-09-14 |
| Urea (BUN) (K051087 | K051087) | MODERATE Effective Date: 2009-09-14 |
| Uric acid (K051087 | K061655) | MODERATE Effective Date: 2009-09-14 |
| Valproic acid (K051087 | K061655) | MODERATE Effective Date: 2009-09-14 |
| Vancomycin (K051087 | K061655) | MODERATE Effective Date: 2009-09-14 |
| Vitamin B12 (K051087 | K071224) | MODERATE Effective Date: 2009-09-14 |
Other Siemens Dimension Vista 1000T Medical Devices:
| Medical Device | Complexity |
| Siemens Dimension Vista 1000T System (20344) Cyclosporine | Methaqualone | | View Complexity |